Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Laura Knecht

Endocrinology, Diabetes & Metabolism Cave Creek, AZ Medical Doctor

NPI 1477752236 CMS profile 338906

6725 E Dove Valley Rd, Cave Creek, AZ 85331

Open in the dashboard

General payments

$141,787

299 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Laura Knecht of Cave Creek, AZ is reported in the CMS Open Payments database as having received $141,787 across 299 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Endocrinology, Diabetes & Metabolism profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $101 1
2024 General $172 2
2022 General $47 2
2020 General $26,790 53
2019 General $114,677 241

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Laura Knecht
  • Endocrinology, Diabetes & Metabolism median
  • Middle half of Endocrinology, Diabetes & Metabolism
  • National median

In program year 2025, general payments to Laura Knecht were reported at $101. Among 5,868 Endocrinology, Diabetes & Metabolism profiles paid that year, the median was $507 and the middle half received between $135 and $1,838.

Show as a table
Year Laura Knecht Endocrinology, Diabetes & Metabolism median Middle half National median
2019 $114,677 $494 $123–$2,253 $163
2020 $26,790 $335 $85–$1,841 $114
2021 $0 $398 $88–$1,981 $132
2022 $47 $364 $88–$1,568 $149
2023 $0 $420 $113–$1,614 $160
2024 $172 $440 $121–$1,646 $164
2025 $101 $507 $135–$1,838 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Corcept Therapeutics $128,937 182 payments
  2. Ipsen Biopharmaceuticals, Inc $11,279 16 payments
  3. Lilly USA, LLC $248 21 payments
  4. Abbott Laboratories $150 8 payments
  5. Sanofi-Aventis U.S. LLC $133 9 payments
  6. Mannkind Corporation $127 11 payments
  7. Insulet Corporation $119 6 payments
  8. Janssen Pharmaceuticals, Inc $109 7 payments
  9. Amgen Inc. $107 5 payments
  10. Ferring Pharmaceuticals Inc. $80 4 payments
  11. Other $497 30 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $84,500 34 payments
  2. Travel and Lodging $26,586 63 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $24,558 17 payments
  4. Food and Beverage $6,129 184 payments
  5. Education $14 1 payment
Products named General payments · program years 2019–2025
  1. Korlym $128,937 182 payments
  2. SOMATULINE DEPOT $11,279 16 payments
  3. TRULICITY $188 16 payments
  4. AFREZZA $127 11 payments
  5. Omnipod $119 6 payments
  6. INVOKANA $109 7 payments
  7. SOLIQUA 100/33 $92 6 payments
  8. INVOKAMET $82 5 payments
  9. ZOMACTON $80 4 payments
  10. FreeStyle Libre $79 5 payments
  11. Other $1,033 68 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

299 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Endocrinology, Diabetes & Metabolism in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record